Insulin glargine and lixisenatide and Zolpidem Extended Release
Determining the interaction of Insulin glargine and lixisenatide and Zolpidem Extended Release and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: zolpidem
Brand name: Ambien, Ambien CR, Edluar, Intermezzo, ZolpiMist
Synonyms: Zolpidem
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Zolpidem Extended-Release Tablets
- Insulin glargine and lixisenatide-Zolpidem Oral Spray
- Insulin glargine and lixisenatide-Zolpidem Oral, Oromucosal
- Insulin glargine and lixisenatide-Zolpidem Sublingual
- Insulin glargine and lixisenatide-Zolpidem Sublingual Tablets (Edluar)
- Insulin glargine and lixisenatide-Zolpidem Sublingual Tablets (Intermezzo)
- Zolpidem Extended Release-Insulin glargine and lixisenatide Subcutaneous
- Zolpidem Extended Release-Insulin glargine, recombinant Subcutaneous
- Zolpidem Extended Release-Insulin glulisine
- Zolpidem Extended Release-Insulin Glulisine (Cartridges and Pens)
- Zolpidem Extended Release-Insulin Glulisine (Vials)
- Zolpidem Extended Release-Insulin glulisine Subcutaneous